NIH-funded research R37 grant

Charcoal-filtered cigarettes and real-world use: how design and perceptions affect smoking and exposures

Official title: A randomized trial of charcoal-filtered cigarettes on product perceptions, smoking behaviors, and toxicant exposure

Funded at Rutgers Biomedical and Health Sciences · NIH-11393185 · Data updated 2026-11-12

This NIH grant tests whether charcoal-filtered cigarettes change how people smoke, what they think about the product, and their exposure to harmful substances.

More Smoking research and trials

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionRutgers Biomedical and Health Sciences
NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project startAugust 14, 2025
Project endJuly 31, 2030
Funding year2026
Award (this year)$664,580
NIH project number5R37CA296976-02
Project IDNIH-11393185 on NIH RePORTER

Who could benefit from this research

Could help

Adults who currently smoke and may be considering lighter or alternative-filtered cigarettes could participate.

Less likely to help

Non-smokers or individuals not using cigarettes would not directly benefit from this study.

What this research studies

The study focuses on adult smokers to understand if switching to charcoal-filtered cigarettes changes their smoking behavior and toxicant exposure in real life, not just in the lab. Researchers will compare charcoal-filtered options to traditional filters, considering how filter design and consumer perceptions influence decisions and usage. The project will collect data from participants over time to observe actual smoking patterns and biomarker changes, aiming to reflect everyday experiences rather than controlled laboratory conditions.

Why it matters

Potential benefit: If successful, the study could clarify whether charcoal filters reduce real-world toxicant exposure and inform safer product design and consumer guidance.

How similar studies have gone: Past laboratory studies suggested potential reductions in some toxicants, but real-world evidence is needed to confirm benefits.

Where this research is happening

  • Rutgers Biomedical and Health Sciences
    Newark, United States
    Active

Researchers

  • Principal investigator: Mercincavage, Melissa — Rutgers Biomedical and Health Sciences
  • Study coordinator: Mercincavage, Melissa

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.